169 related articles for article (PubMed ID: 28750235)
1. Investigation of the effect of plasma albumin levels on regorafenib-induced hepatotoxicity using a validated liquid chromatography-tandem mass spectrometry method.
Pang YY; Tan YL; Ho HK
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():220-224. PubMed ID: 28750235
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2014 Oct; 28(10):1366-70. PubMed ID: 24619951
[TBL] [Abstract][Full Text] [Related]
3. A LC-MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma.
Iacuzzi V; Zanchetta M; Gagno S; Poetto AS; Orleni M; Marangon E; Guardascione M; Foltran L; Posocco B; Toffoli G
J Pharm Biomed Anal; 2020 Aug; 187():113358. PubMed ID: 32460216
[TBL] [Abstract][Full Text] [Related]
4. Determination of regorafenib (BAY 73-4506) and its major human metabolites BAY 75-7495 (M-2) and BAY 81-8752 (M-5) in human plasma by stable-isotope dilution liquid chromatography-tandem mass spectrometry.
Hafner FT; Werner D; Kaiser M
Bioanalysis; 2014; 6(14):1923-37. PubMed ID: 25158964
[TBL] [Abstract][Full Text] [Related]
5. Quantification of liensinine in rat plasma using ultra-performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
Lv SF; Wang XH; Li HW; Zhang XL; Wang B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 992():43-6. PubMed ID: 25939097
[TBL] [Abstract][Full Text] [Related]
6. Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Cardoso E; Mercier T; Wagner AD; Homicsko K; Michielin O; Ellefsen-Lavoie K; Cagnon L; Diezi M; Buclin T; Widmer N; Csajka C; Decosterd L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():124-136. PubMed ID: 29544202
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS.
Allard M; Khoudour N; Rousseau B; Joly C; Costentin C; Blanchet B; Tournigand C; Hulin A
J Pharm Biomed Anal; 2017 Aug; 142():42-48. PubMed ID: 28494338
[TBL] [Abstract][Full Text] [Related]
8. Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS.
Krens SD; van der Meulen E; Jansman FGA; Burger DM; van Erp NP
Biomed Chromatogr; 2020 Mar; 34(3):e4758. PubMed ID: 31758580
[TBL] [Abstract][Full Text] [Related]
9. A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
van Erp NP; de Wit D; Guchelaar HJ; Gelderblom H; Hessing TJ; Hartigh Jd
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():33-43. PubMed ID: 24013127
[TBL] [Abstract][Full Text] [Related]
10. Rapid determination of ruscogenin in rat plasma with application to pharmacokinetic study.
Ji PY; Li ZW; Yang Q; Wu R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():71-4. PubMed ID: 25660717
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
[TBL] [Abstract][Full Text] [Related]
12. A simple method for the determination of Bosutinib in rat plasma by UPLC-MS/MS.
Xu Y; Huang XC; Dai S; Xiao Y; Zhou MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():93-7. PubMed ID: 26454795
[TBL] [Abstract][Full Text] [Related]
13. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Dogan-Topal B; Li W; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():116-123. PubMed ID: 30802754
[TBL] [Abstract][Full Text] [Related]
14. An LC-MS/MS method for the quantitation of cabozantinib in rat plasma: application to a pharmacokinetic study.
Su Q; Li J; Ji X; Li J; Zhou T; Lu W; Li L
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():119-23. PubMed ID: 25678398
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-throughput method for the quantitative analysis of D-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic study.
Cesari N; Fontana S; Montanari D; Braggio S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):21-8. PubMed ID: 19945359
[TBL] [Abstract][Full Text] [Related]
16. An LC-MS/MS method for simultaneous determination of trantinterol and its major metabolite in rat plasma and its application to a comparative pharmacokinetic study.
Wang Y; Qin F; Xiong Z; Fu X; Ma C
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():163-8. PubMed ID: 26245359
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
Ding J; Chen X; Dai X; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():108-15. PubMed ID: 22503745
[TBL] [Abstract][Full Text] [Related]
18. Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies.
Ramalingam P; Ko YT
J Pharm Biomed Anal; 2016 Feb; 119():71-5. PubMed ID: 26657178
[TBL] [Abstract][Full Text] [Related]
19. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study.
Tang J; Zhu R; Zhao R; Cheng G; Peng W
J Pharm Biomed Anal; 2008 Aug; 47(4-5):923-8. PubMed ID: 18534803
[TBL] [Abstract][Full Text] [Related]
20. Determination of parthenolide in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Zhao AQ; Zhao JH; Zhang SQ; Pan YY; Huo XL
J Pharm Biomed Anal; 2016 Feb; 119():99-103. PubMed ID: 26678176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
